Show simple item record

dc.contributor.authorWinnicka, Adrianna
dc.date.accessioned2024-09-24T10:27:56Z
dc.date.available2024-09-24T10:27:56Z
dc.date.issued2024-09-18
dc.identifier.issn1730-2366
dc.identifier.urihttp://hdl.handle.net/11089/53220
dc.language.isoen
dc.publisherWydawnictwo Uniwersytetu Łódzkiegopl
dc.relation.ispartofseriesActa Universitatis Lodziensis. Folia Biologica et Oecologicaen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.subjectglioblastoma multiformeen
dc.subjectimmunotherapyen
dc.subjectimmune checkpoint inhibitorsen
dc.subjectmonoclonal antibodiesen
dc.subjectneurooncologyen
dc.titleImmune checkpoint inhibitors in the treatment of glioblastoma multiformeen
dc.typeArticle
dc.page.number13-13
dc.contributor.authorAffiliationUniversity of Lodz, Faculty of Biology and Environmental Protection, Polanden
dc.identifier.eissn2083-8484
dc.referencesYasinjan, F., Xing, Y., Geng, H., Guo, R., Yang, L., Liu, Z., Wang, H. 2023. Immunotherapy: a promising approach for glioma treatment. Frontiers in Immunology, 14, 1255611.en
dc.referencesLinares, C.A., Varghese, A., Ghose, A., Shide, S.D., Adeleke, S., Sanchez, E., Sheriff, M., Chargari, C., Rassy, E., Boussios, S. 2023. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities. International Journal of Molecular Sciences, 24(17), 13215.en
dc.contributor.authorEmailadrianna.winnicka@edu.uni.lodz.pl
dc.identifier.doi10.18778/1730-2366.18.05
dc.relation.volume18


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0